In summary, we found for the first time that SA specifically promoted the differentiation and maturation of OPCs via the PI3 K/Akt/mTOR signaling pathway, alleviated the severity of EAE, and accelerated remyelination in the LPC model, suggesting the therapeutic potential of SA for demyelinating diseases. The gene discussed is AKT1; the disease is demyelinating disease.